HYVET Trial The Hypertension in the Very Elderly Trial (HYVET)
HYVET Trial The Hypertension in the Very Elderly Trial (HYVET)
HYVET Trial The Hypertension in the Very Elderly Trial (HYVET)
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>HYVET</strong> <strong>Trial</strong>: OutcomesMa<strong>in</strong> Fatal and Nonfatal End Po<strong>in</strong>ts <strong>in</strong> <strong>the</strong> Intention-to-Treat PopulationEnd Po<strong>in</strong>tDeath from cardiaccause*Rate per 1000 Patient-Yr (No. of Events)IndapamideNo. (%)PlaceboUnadjustedHazard Ratio(95% CI) p-value6.0 (25) 8.4 (33) 0.71 (0.42-1.19) 0.19Death from heart failure 1.5 (6) 3.0 (12) 0.48 (0.18-1.28) 0.14Any fatal or nonfatal MI 2.2 (9) 3.1 (12) 0.72 (0.30-1.70) 0.45Any fatal or nonfatal heartfailureAny fatal or nonfatalcardiovascular event**5.3 (22) 14.8 (57) 0.36 (0.22-0.58)
Change language